Current Rating and Its Significance
MarketsMOJO’s 'Hold' rating for Granules India Ltd indicates a balanced outlook on the stock. It suggests that while the company demonstrates solid operational and financial characteristics, the stock may not offer significant upside potential relative to its current price. Investors are advised to maintain their positions without aggressive buying or selling, awaiting clearer signals from future performance or market developments.
Quality Assessment
As of 13 February 2026, Granules India Ltd exhibits a good quality grade. This is supported by its high management efficiency, reflected in a robust Return on Capital Employed (ROCE) of 17.70%. Such a figure indicates that the company is effectively generating profits from its capital base, a key indicator of operational strength. Additionally, the company maintains a low Debt to EBITDA ratio of 0.97 times, underscoring its strong ability to service debt and maintain financial stability.
Valuation Perspective
The stock’s valuation is currently graded as fair. Granules India Ltd trades at an Enterprise Value to Capital Employed ratio of 2.9, which is below the average historical valuations of its peers, suggesting a discount in the market price. The company’s ROCE of 14.4% aligns with this valuation, indicating that the stock is reasonably priced relative to its capital efficiency. Furthermore, the Price/Earnings to Growth (PEG) ratio stands at 2, reflecting moderate expectations for growth relative to earnings, which supports the 'Hold' stance.
Financial Trend Analysis
Examining the financial trends as of 13 February 2026, Granules India Ltd shows a positive financial grade. The company’s operating profit has grown at an annualised rate of 5.92% over the past five years, signalling steady, albeit modest, long-term growth. Recent quarterly results reinforce this trend, with net sales reaching a record high of ₹1,387.94 crores and an operating profit to interest coverage ratio of 10.74 times, indicating strong earnings relative to interest expenses. Cash and cash equivalents also stand at a healthy ₹619.01 crores, providing liquidity and operational flexibility.
Technical Outlook
From a technical standpoint, the stock is rated as mildly bullish. Over the past six months, Granules India Ltd has delivered a notable 23.42% return, reflecting positive momentum. However, shorter-term movements have been mixed, with a 3.90% decline over the past month and a 5.09% decrease year-to-date. The stock’s one-year return of 5.01% indicates moderate appreciation, consistent with the 'Hold' rating that suggests neither strong buy nor sell signals at present.
Stock Performance and Market Position
Currently, the company is classified as a smallcap within the Pharmaceuticals & Biotechnology sector. Institutional investors hold a significant 31.03% stake, which often implies confidence from knowledgeable market participants who have the resources to analyse company fundamentals thoroughly. This institutional backing can provide stability to the stock price and may influence future performance positively.
Despite the positive aspects, the company’s long-term growth rate remains modest, and the valuation, while fair, does not suggest a compelling bargain. Investors should weigh these factors carefully when considering their portfolio allocation.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Implications for Investors
For investors, the 'Hold' rating on Granules India Ltd suggests a cautious approach. The company’s strong management efficiency and solid financial health provide a foundation of stability. However, the fair valuation and moderate growth prospects imply limited immediate upside. Investors currently holding the stock may consider maintaining their positions, while those looking to enter might wait for clearer signals of acceleration in growth or a more attractive valuation.
Sector and Market Context
Operating within the Pharmaceuticals & Biotechnology sector, Granules India Ltd faces a competitive environment with evolving regulatory and market dynamics. The sector often rewards companies with strong innovation pipelines and robust financials. Granules’ current metrics suggest it is well-positioned operationally but may need to demonstrate stronger growth momentum to move beyond a 'Hold' rating.
Summary of Key Metrics as of 13 February 2026
- Mojo Score: 68.0 (Hold Grade)
- ROCE: 17.70%
- Debt to EBITDA: 0.97 times
- Operating Profit Growth (5 years CAGR): 5.92%
- Net Sales (Quarterly): ₹1,387.94 crores
- Operating Profit to Interest Coverage: 10.74 times
- Cash and Cash Equivalents (Half Yearly): ₹619.01 crores
- Enterprise Value to Capital Employed: 2.9
- PEG Ratio: 2
- Institutional Holdings: 31.03%
- Stock Returns: 1D -0.24%, 1W +0.67%, 1M -3.90%, 3M +2.20%, 6M +23.42%, YTD -5.09%, 1Y +5.01%
These figures collectively underpin the current 'Hold' rating, reflecting a company with solid fundamentals and reasonable valuation but without strong catalysts for immediate outperformance.
Looking Ahead
Investors should monitor Granules India Ltd’s upcoming quarterly results and sector developments closely. Any significant acceleration in profit growth or improvement in valuation metrics could prompt a reassessment of the stock’s rating. Until then, the 'Hold' recommendation remains appropriate, balancing the company’s strengths against its current market pricing and growth outlook.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
